Lipid profile measurement

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the...

Multiple Chemical Sensitivity Syndrome

Horse Serum Merck

Haemophilus b Vaccine Merck

Merck KGaA: Company Profile

Merck KGaA, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years. Return to top 50 pharma list Summary Merck KGaA  is a top...

Merck & Co: Company profile

Return to top 50 pharma list Summary Website: Merck & Co Headquarters: Whitehouse Station, NJ, USA Ticker: MRK (NYSE) SEC: Merck & Co Recent deal news: Merck & Co deal news at Current Part...

Merck KGaA

Merck KGaA  is a top pharmaceutical company based in Darmstadt, Germany. The company was founded in 1668 and is the oldest pharmaceutical and chemical company in the world. Merck stands for innovati...

The Merck Index

So the Royal Society of Chemistry has bought the Merck Index, and plans to try to raise its profile, especially online. I wish them luck, but I'm not sure how well that's going to work out. I have a c...

Merck Serono collaborates with Nordic Bioscience for sprifermin in osteoarthritis

German drug and chemical major Merck KGaA (MRK: DE) says its Merck Serono division has entered into a strategic alliance with Danish drug developer Nordic Bioscience Clinical Development on Merck Sero...

Merck shares fall on worries about osteoporosis drug

(Reuters) - Merck & Co Inc's quarterly results beat estimates, but the drugmaker issued a cautious 2013 profit forecast and said it will delay seeking approval for a high-profile osteoporosis...

Fitch Affirms Merck & Co.'s IDR at 'A+'; Outlook Negative

(The following statement was released by the rating agency) CHICAGO, May 03 (Fitch) Fitch Ratings has affirmed Merck & Co.'s (Merck) ratings, including the Issuer Default Rating (IDR) at 'A+'. The Rat...

Merck & Co closes odanacatib trial early on good results in osteoporosis

US drug giant Merck & Co (NYSE: MRK) says it is halting a Phase III trial of its investigational osteoporosis drug odanacatib early on the recommendation of the independent Data Monitoring Committee d...

Strategies towards Improving the Pharmacokinetic Profile of ε-Substituted Lysinol-Derived HIV Protease Inhibitors.

Re: longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Expert Commentary-Unusual Headache Syndromes.

Three-drug combination regimen in pancreatic cancer treatment: are we there yet?

Comments on 'Sample size for equivalence trials: a case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona.